Mototsugu Tanaka
10PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 15, 2025
In Vitro Diagnostics for SARS-CoV-2 Infection Authorized in the United States and Approved in Japan.Mayumi Idei, Kiyoshi Asada, Mototsugu Tanaka
|Nov 08, 2024
Concordance Between Pharmaceuticals and Medical Devices Agency Review and Ministry of Health, Labour and Welfare Decision Among New Drug Applications in Japan.Makoto Miyazawa, Mototsugu Tanaka, Yusuke Tanaka
|Apr 23, 2024
Postmarket safety communications on drugs approved in Japan: A 25-year analysis.Yusuke Tanaka, Mototsugu Tanaka, Haruna Miyazawa
|May 10, 2023
Conditional early approval for new drug applications in Japan: Current and emerging issues.Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima
|Dec 28, 2021
Effluent N-terminal expressed in renal cell carcinoma/mesothelin predicts increased peritoneal permeability in patients undergoing peritoneal dialysis.Mayumi Idei, Masaaki Abe, Mototsugu Tanaka
|Mar 11, 2021
Achievements and challenges of the Sakigake designation system in Japan.Mototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi
Pageof 2
